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Serotonin deficiency induced 
after brain maturation rescues 
consequences of early life adversity
B. Aboagye1,7, T. Weber4,5, H. L. Merdian6, D. Bartsch4, K. P. Lesch1,2,3,8* & J. Waider1,8*
Brain serotonin (5-HT) system dysfunction is implicated in depressive disorders and acute depletion 
of 5-HT precursor tryptophan has frequently been used to model the influence of 5-HT deficiency 
on emotion regulation. Tamoxifen (TAM)-induced Cre/loxP-mediated inactivation of the tryptophan 
hydroxylase-2 gene (Tph2) was used to investigate the effects of provoked 5-HT deficiency in adult 
mice (Tph2 icKO) previously subjected to maternal separation (MS). The efficiency of Tph2 inactivation 
was validated by immunohistochemistry and HPLC. The impact of Tph2 icKO in interaction with MS 
stress (Tph2 icKO × MS) on physiological parameters, emotional behavior and expression of 5-HT 
system-related marker genes were assessed. Tph2 icKO mice displayed a significant reduction in 
5-HT immunoreactive cells and 5-HT concentrations in the rostral raphe region within four weeks 
following TAM treatment. Tph2 icKO and MS differentially affected food and water intake, locomotor 
activity as well as panic-like escape behavior. Tph2 icKO prevented the adverse effects of MS stress 
and altered the expression of the genes previously linked to stress and emotionality. In conclusion, 
an experimental model was established to study the behavioral and neurobiological consequences 
of 5-HT deficiency in adulthood in interaction with early-life adversity potentially affecting brain 
development and the pathogenesis of depressive disorders.
Brain serotonin (5-HT) system dysfunction is implicated in disorders of emotion regulation, such as anxiety and 
depression, viewed as multifactorial conditions influenced by multiple gene-by-gene and gene-by-environment 
 interactions1. Previous research identified genetic variants regulating the expression of the gene encoding the 
rate-limiting enzyme of neuronal serotonin (5-HT) synthesis, tryptophan hydroxylase-2 (TPH2)2,3, which con-
verts the essential amino acid tryptophan (TRP) into 5-OH-TRP, the direct precursor of 5-HT4,5.
Depletion of TRP by dietary intervention (acute TRP depletion, ATD) has traditionally been used in assessing 
the influence of 5-HT deficiency on emotion dysregulation and the pathogenesis of depressive disorders. TRP-
free diet produces an acute and profound reduction in brain TRP and consequently brain 5-HT  synthesis6–8. 
ATD decreases anxiety in patients with anorexia  nervosa9 and also lowered mood in healthy participants and 
individuals with bulimia  nervosa10,11. However, the mechanisms of ATD and the impact of reduced brain 5-HT 
on behavior are still not well  understood12. Animal model studies provide evidence for alterations in brain 5-HT 
release following ATD, resulting in altered anxiety- and depression-related  behavior13.
Genetic manipulation in mice, which results in embryonic inactivation of Tph2 or other 5-HT neuron devel-
opment-related genes (e.g. Pet1, Lmx1b), provided insight into the behavioral and physiological consequences 
of 5-HT deficiency in the  brain14,15. Several studies showed that neonates with a constitutive Tph2 inactivation 
present viability and growth-related problems compared to wildtype  counterparts16,17. While these mice retain 
normal 5-HT neuron morphology and physiology, and are indistinguishable from controls in  adulthood18,19, 
several behavioral phenotypes have been  reported20–22. These phenotypes arising from lifelong Tph2 inactiva-
tion may be the consequence of impaired functioning of other relevant genes, the expression of which is, at least 
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partly, dependent on 5-HT during brain  maturation23,24 and may result in structural and functional differences 
of the networks involved in emotional processing of mice lacking  Tph225.
Here, we used Tamoxifen (TAM)-induced Cre/loxP-mediated inactivation of the Tph2 to investigate the 
effects of provoked 5-HT deficiency in the modulation of emotional responses and risk for anxiety disorders 
and depression in interaction with environmental adversity during brain maturation in adult mice (Tph2 icKO) 
previously subjected to maternal separation (MS).
Material and methods
Animals. In this study only male mice were used. They were housed in groups in a controlled environment 
(12/12 h light/dark cycle, 21 ± 0.5 °C room temperature, 50 ± 5% humidity) with food and water ad libitum. Mice 
were acclimatized to single housing conditions for ≥ 3 weeks prior to behavioral experiments. Behavioral tests 
were performed during the light phase between 10:00 and 15:00 with a recovery period of 7 days between dif-
ferent tests. All in vivo animal experiments were performed in accordance with the European Parliament and 
Council Directive (2010/63/EU) and ARRIVE guidelines. The study was approved by the institutional review 
board of the University of Würzburg and the Government of Lower Franconia (55.2-2531.01-57/12).
Induction of Tph2 inactivation. For temporal and spatial control of Tph2 recombination, mice homozy-
gous for Tph2 exon five flanked by loxP-sites (Tph2fl/fl), the palindromic recognition sites of Cre  recombinase26 
backcrossed onto a C57Bl/6N background were crossed with Tph2 null mutant mice (Tph2−/−)to generate Tph2fl/− 
hemizygous mice, which lack one Tph2 allele from the beginning of their life similar to heterozygous Tph2 
knockout mice (Tph2+/−). These mouse lines were crossed with C57Bl/6N.TgTph2creERT2 transgenic mice, which 
express CreERT2 under the control of the murine Tph2 promoter exclusively in the raphe nuclei , to gener-
ate  TgTph2creERT2/Tph2fl/fl and  TgTph2creERT2/Tph2fl/− mice respectively.  TgTph2creERT2/Tph2fl/fl or  TgTph2creERT2/Tph2fl/− 
males were crossed with non-transgenic females in order to control the number of Tph2creERT2 transgenes 
(n = 1) in the animals. In order to initiate Cre/loxP-mediated recombination to generate an induced raphe nuclei 
specific Tph2 knockout (Tph2icKO), male  TgTph2creERT2/Tph2fl/fl or  TgTph2creERT2/Tph2fl/− mice aged 10–12 weeks 
were injected twice a day for 5 consecutive days with 1 mg of Tamoxifen (TAM; Sigma Aldrich, St. Louis, USA)27 
resulting in Tph2Δfl/− mice or Tph2Δfl/fl. In this respectTph2Δfl/− mice model an Tph2icKO based on a hemizy-
gous background, while Tph2Δfl/fl mice model an Tph2icKO based on a wildtype like genetic background during 
development.  TgTph2creERT/Tph2+/+ mice injected with TAM (Tph2Δ+/+) were used as controls. Vehicle injected 
mice of same genotype were used as controls in the maternal separation experiments (Tph2 CON).
Immunohistochemistry. The efficacy of TAM-induced time-specific Tph2 inactivation in the brainstem 
raphe region was assessed by fluorescence immunohistochemistry in the 4th and 6th week after treatment. Thin 
sections (30 µm) of brain of mice (n = 7–9/group) were cut on cryostat and stored at − 80 °C. Frozen sections 
were dried for 15–20 min. An antigen retrieval was conducted as previously  described26. Sections were cooled 
down to 40 °C and washed 3 × 5 min in Tris-buffered saline (TBS). Unspecific binding sites for the antibod-
ies were blocked for 90 min at room temperature (RT) with blocking solution (5% normal goat serum, 0.25% 
Triton-X100 in TBS). Sections were incubated overnight with the primary antibody (1:400, goat-anti 5-HT; 
Immunostar; Hudson; USA) diluted in blocking solution (TBS-T) at 4 °C in a humid chamber. Following three 
5-min washing steps in TBS, sections were incubated in the dark with the respective fluorescent secondary 
antibodies (1:400 Cy3) diluted in blocking solution, lasting 90 min. Sections were washed 3 × 5 min in TBS. For 
staining of the cell nuclei, sections were treated with 300 µm DAPI diluted 1:1000 in TBS for 5 min. The number 
raphe neurons that were immunoreactive (ir) for 5-HT in dorsal (DRN: B6, B7) and median raphe nuclei (MRN: 
B5, B8, B9)28,29 based on cell nuclei surrounded by anti-Tph2 signal using Fiji  software30 on four consecutive 
pictures of anterior raphe (DRN and MRN) corresponding to Bregma—4.95 mm to—4.47 mm spaced 180 µm31.
Neurochemistry. For high performance liquid chromatography (HPLC), three brain regions (hippocam-
pus, the dorsal raphe and the amygdaloid complex) were quickly dissected under a stereo microscope. For this, 
the brain (n = 4–7) was sliced with the aid of a metallic matrix, which allows sectioning at equal intervals on a 
cold plate. The identified regions were dissected out with a preparation spatula and kept frozen at − 80 °C until 
use. The brain homogenates were prepared and analyzed to standard  protocols19,25.
Body weight and food intake. Body weight of mice (n = 18–25) used for the baseline behavioral study 
was measured weekly for 7 weeks starting from the first week of injection. Body-weight measurements were 
conducted from 10 to 11 a.m. Two weeks after the last injection, mice were single-housed and their food and 
water-intake was measured weekly.
Behavioral assessment. Mice were subjected to behavioral testing starting from 4 weeks after TAM injec-
tions. In the baseline study, one group of mice (n = 13–15/group) was first tested for anxiety-like behavior in the 
light–dark transition test (LDT), followed by an open-field test (OF) to assess locomotor activity in a novel ines-
capable  environment32. A second group of mice (n = 7–11/group) was used to assess anxiety- and depression-
like behaviour including an elevated-plus maze test (EPM), sucrose preference test and lastly Porsolt swim test 
(PST)33. Observations were recorded with VideoMot2 (TSE Systems, Bad Homburg, Germany) and later ana-
lyzed with EthoVision XT 11.5 (Noldus, Wageningen, The Netherlands). For details see supplementary methods.
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Maternal separation. In the second study, pups of the  TgTph2creERT2/Tph2fl/fl genotype were separated on the 
second postnatal day (P2) from their mothers and kept in fresh cages for 3 h daily (between 10.00 and 13.00), for 
14 consecutive days (P2-16). Ambient temperature was ensured by infrared light, positioned 70 cm above the 
cage. Non-MS mice were not separated from the dams but were handled during routine cage changes. Mice were 
weaned at 25 days after birth and kept in groups of 2 to 5 mice per cage and injected with either TAM (Tph2Δfl/fl) 
or vehicle (CON) (n = 8–10/group). After 4 weeks, mice were tested for anxiety-related behavior in the EPM, 
LBD and OF followed by SPT and FST for depression related behavior with 3 days inter-trial time, all tests were 
done as described in supplementary methods.
Quantitative real-time PCR. Quantification of relative gene expression was performed by quantita-
tive real-time PCR (qRT-PCR). cDNA was generated as previously  described34. The reaction was run in trip-
licates using SYBR green dye according to manufacturer instructions. Reaction mixture comprised 6 µl (SYBR 
green + Primer (F + R)) mix and 4 µl cDNA making 10 µl reaction volume each. Mean efficiencies were calculated 
by  LinReg35. Relative expression data were calculated by qBase + (Biogazelle, Zwijnaarde, Belgium), with the 
normalization factors obtained from geNorm (geNorm M < 0.5)36. Reference genes: glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH_3), beta-2 microglobulin (B2m_2), ubiquitin C (UBC_1) and ribosomal protein lateral 
stack subunit P0 (Rplpo). Selected target genes were tryptophan hydroxylase 2 (Tph2), 5-HT receptor 1a (Htr1a), 
5-HT receptor 2a (Htr2a), monoamine oxidase A (Maoa), arginine vasopressin receptor 1a (Avpr1a).
Data analysis. Data obtained from this study were analyzed and displayed using GraphPad Prism version 
6.07 for Windows (GraphPad Software, La Jolla California USA, www.graph pad.com). The total numbers of 
5-HT ir cells counted in the anterior raphe of Tph2 icKO were compared with that of Tph2 CON mice using 
Kruskal–Wallis statistic (H), while Dunn’s multiple comparison test was used to compare means between the 
groups of mice.
Behavioral outcomes on baseline anxiety- and depression-like behavior were analyzed by one-way ANOVA. 
The course of 5-HT depletion from week 2, 4 and 6 were analyzed by two-way ANOVA as well as MS and gene 
expression data, with Tukey’s multiple comparison post hoc test used to compare means. Students t-test was used 
for comparisons between Tph2Δ+/+ and Tph2fl/fl mice (Figs. S1 and S2). An α < 0.05 was set as level of significance.
Results
Efficiency of induced Tph2 inactivation. The half-life of Tph2 is approximately 2.5   days37. Thus, we 
first evaluated the time required after induced Tph2 recombination to reduce the amount of Tph2 synthesis to 
a level similar to constitutive Tph2 KO mice  by immunohistochemistry (Fig. 1a). Four weeks after TAM treat-
ment, effective recombination of Tph2 was indicated by a significant drop of 5-HT ir cells in the DRN (Fig. 1b) 
of Tph2 icKO compared with Tph2 CON mice [(H2) = 7.731; p = 0.0066; Fig. 1b, right panel]. The number of 
5-HT ir cells in the raphe region of Tph2Δfl/− (p = 0.0107) and Tph2Δfl/fl (p = 0.0789) mice was reduced by 97.6% 
and 95.0% respectively compared to Tph2Δ+/+ mice. After six weeks following TAM injection, only a few scat-
tered 5-HT ir cells were observed in the DRN (Fig. 1b) in Tph2Δfl/− and Tph2Δfl/fl in comparison to Tph2Δ+/+ mice 
(H2) = 16.43; p = 0.0003; Fig. 1b, right panel). Tph2Δfl/fl (p = 0.0006) and Tph2Δfl/− (p = 0.0023) showed a 93.7% and 
92.2% reduction of 5-HT ir cells compared to Tph2Δ+/+ mice. Similar to the DRN, the number of 5-HT ir cells 
in the MRN was decreased in Tph2 icKO after four weeks ((H2) = 16.65; p = 0.0002) and six weeks after treat-
ment ((H2) = 7.758; p = 0.0062). Compared to Tph2Δ+/+ mice, a significantly reduced number of 5-HT ir cells in 
Tph2Δfl/fl (p = 0.0053) and Tph2Δfl/− (p = 0.0003) was detected by week four. Similar observations were recorded 
by week six in Tph2Δfl/fl (p = 0.0783) and Tph2Δfl/− (p = 0.016), which accounted for 92.7% and 82.1% reduction, 
respectively (Fig. 1c). Of note the number of 5-HT ir cells in DRN and MNR of Tph2Δ+/+ mice did not differ to 
vehicle treated Tph2fl/fl mice (Fig. S1).
Neurochemistry. In order to relate the absence of 5-HT ir cells to concentrations of monoamines in the 
raphe and target brain regions, we measured the concentrations of 5-HT and its metabolite, 5-hydroxyindola-
cetic acid (5-HIAA), as well as norepinephrine (NE) and dopamine (DA) in the raphe, hippocampus and amyg-
dala at all three time points after TAM induction. Two-way ANOVA revealed a tendency towards significance 
in the raphe for genotype × time interaction  (F(4,40) = 2.299; p = 0.0756). Indeed, from week 2 to 6 Tph2Δ+/+ pre-
sented increased 5-HT concentrations (p = 0.0032) in the brainstem at a comparable level to wildtype (Tph2+/+) 
 controls19, and showed significantly higher concentrations compared to Tph2Δfl/− (p = 0.016) and Tph2Δfl/fl 
(p = 0.0783) mice. The concentration of 5-HT in Tph2Δfl/− and Tph2Δfl/fl mice was relatively stable at all time 
points, remaining at low concentrations (67.0 ± 13.6 ng/ml), similar to those reported in constitutive Tph2−/− 
 mice19 (Fig. 2a, left panel). Moreover, the concentrations of the 5-HT metabolite 5-HIAA remained consistently 
low in both genotypes of Tph2 icKO mice at all time points examined. However, two-way ANOVA revealed a 
significant genotype × time interaction  (F(4,40) = 8.157; p < 0.0001; Fig. 2b, left panel), showing higher 5-HIAA in 
Tph2Δ+l+ compared to Tph2Δfl/fl and Tph2Δfl/− (both p < 0.0001) only two weeks after injections.
In the hippocampus a significant genotype × time interaction was detected  (F(4,40) = 6.493; p = 0.0004; Fig. 2a, 
middle panel). Similar to the raphe, a rise in 5-HT concentrations in Tph2Δ+/+ mice from week 2 to 6 was 
observed. The amount of 5-HT detected in Tph2Δ+l+ was considerably higher than Tph2Δfl/fl (p = 0.017) and 
Tph2Δfl/− (p = 0.0013) in week 6. However, in contrast to the raphe, Tph2Δfl/fl had higher concentrations of 5-HT 
at week 2, which declined until week 6, whereas in Tph2Δfl/− mice low 5-HT concentrations were detected at all 
time points. This provides evidence that recombination of two functional Tph2 alleles requires more time to effect 
changes in 5-HT concentrations in hippocampal projections. Furthermore, hippocampal 5-HIAA concentra-
tions revealed a significant genotype × time interaction  (F(4,40) = 4.776; p = 0.003; Fig. 2b, middle panel). In week 
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2, Tph2Δ+l+ displayed significantly higher concentrations of 5-HIAA than Tph2Δfl/fl and Tph2Δfl/− (both p < 0.0001) 
like in the brainstem, which was also detected in week 4 [Tph2Δfl/fl (p = 0.0767); Tph2Δfl/− (p = 0.0258)] and week 
6 [Tph2Δfl/fl (p = 0.0683); Tph2Δfl/− (p = 0.0285)] also less pronounced.
In the amygdala a significant genotype × time interaction effect was observed  (F(4,40) = 9.316; p < 0.0001; Fig. 2a, 
right panel). Similar to the other brain regions, 5-HT concentrations in Tph2Δ+/+ was significantly lower com-
pared to Tph2Δfl/fl (p = 0.0023) and Tph2Δfl/− (p = 0.0214) at week two after induction and increased towards week 
6 resulting in higher concentrations of 5-HT than Tph2Δfl/fl (p = 0.0004) and Tph2Δfl/− (p = 0.0044). However, no 
Figure 1.  Tamoxifen (TAM)-induced Cre/fl-mediated inactivation of the tryptophan hydroxylase-2 (Tph2) 
gene during adulthood in raphe 5-HT neurons of  TgTph2creERT2/Tph2+/+ (Δ+/+),  TgTph2creERT2/Tph2fl/fl (Δfl/fl) and 
 TgTph2creERT2/Tph2fl/- (Δfl/−) mice. (a) Timeline for gene targeting, immunohistochemistry (IHC) and HPLC; (b) 
IHC and quantification of 5-HT positive cells in the dorsal raphe nucleus (DRN) B6 and B7 at week 14 (upper 
panel) and week 16 (lower panel) after treatment; (c) IHC and quantification of 5-HT positive cells in MRN 
at week 14 (upper panel) and week 16 (lower panel) after treatment. Number of 5-HT positive cells counted 
represented as mean ± SEM in week 14 (n = 4/group) and week 16 (n = 6–9). Data are shown as mean ± SEM. 
#0.05 < p < 0.1, *p < 0.05 and ***p < 0.001.
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significant changes were detected over time in Tph2 icKO mice, the concentration of 5-HT remained constantly 
high. Yet, the concentrations of 5-HIAA documented in the raphe, amygdala and hippocampus showed a sig-
nificant genotype × time interaction effect  (F(4,40) = 7.356; p = 0.0002; Fig. 2b right panel). In week 2, Tph2Δ+/+ 
displayed significantly higher concentrations of 5-HIAA compared to Tph2Δfl/fl and Tph2Δfl/− (all p < 0.0001). 
Whereas in week 4, no significant differences were observed, Tph2Δ+/+ showed higher concentrations of 5-HIAA 
than Tph2Δfl/fl (p = 0.0184) and Tph2Δfl/− (p = 0.0114) in week 6.
For NE two-way ANOVA revealed significant genotype × time interaction effects in the raphe  (F(4,40) = 6.327; 
p < 0.0001; Fig. 2c, left panel), hippocampus  (F(4,40) = 9.862; p < 0.0001; Fig. 2c middle panel) and amygdala 
 (F(4,40) = 62.804; p < 0.0001; Fig. 2c, right panel). Post-hoc analyses revealed that in all brain regions Tph2Δ+/+ had 
lower NE concentrations compared to Tph2Δfl/fl and Tph2Δfl/− mice at week 2 (p < 0.0001).
Only in the amygdala a significant genotype × time interaction was detected for the concentrations of DA 
 (F(4,40) = 2.822; p = 0.038; Fig. 2d, right panel). Post-hoc testing showed lower DA in Tph2Δ+/+ compared with 
Tph2Δfl/fl (p = 0.0024) and Tph2Δfl/− (p = 0.0837) at week 2. At week 4 DA concentrations in Tph2Δfl/fl dropped sig-
nificantly compared to week 2 (p = 0.0385). At week 6, no differences between genotypes were detected. Increased 
DA concentrations inTph2Δ+/+ at week 6 approached significance compared to week 2 (p = 0.065), indicating a 
Figure 2.  Concentrations of monoamines in brain of Tph2 induced conditional knockout mice (Tph2+/+, 
Tph2fl/fl, Tph2fl/−). HPLC analysis of 5-HT in raphe, hippocampus and amygdala at week (wk) 2, 4 and 6 after 
induction; (a) 5-HT, (b) 5-HIAA, (c) NE, (d) DA in selected brain regions. Data are shown as mean ± SEM. 
#0.05 < p < 0.1, **p < 0.01, ***p < 0.001 and ωp < 0.001 compared to all groups.
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balancing effect in Tph2Δ+/+ over time. In the raphe (Fig. 2d, left panel) and hippocampus (Fig. 2d, middle panel) 
DA concentrations remained constant beyond all groups.
Locomotor hyperactivity but unaltered anxiety- and depression-like behavior in Tph2 icKO 
mice. After demonstrating the time course of 5-HT reduction after Tph2 icKO induction, we investigated 
anxiety and depressive-like behavior 4–6 weeks after the injections (Fig. 3a). In the OF test, Tph2Δ+/+, Tph2Δfl/− 
and Tph2Δfl/fl mice put up similar performances in the frequency of visits to the aversive center  (F(2,39) = 2.431, 
Figure 3.  Lack of effects on anxiety- and depression-like but increased exploratory behavior in Tph2 icKO 
mice based on hemizygous genetic predisposition (a) Timelines for behaviour testing; (b)–(e) LDB: light box 
visits, time in light box, total distance and vertical rearings; (f)–(h) EPM: open arms visits, time in open arms 
and total distance; (i)–(l) OFT: center visits, time in center, total distance and jumping behavior; (m),(n) FST: 
latency to float and floating duration; (o),(p) SPT: total fluid consumed and sucrose preference. Data are shown 
as mean ± SEM. #0.05 < p < 0.1, **p < 0.01 and ***p < 0.001.
7
Vol.:(0123456789)
Scientific Reports |         (2021) 11:5368  | https://doi.org/10.1038/s41598-021-83592-4
www.nature.com/scientificreports/
p = 0.1012; Fig. 3i) and time spent in center  (F(2,39) = 0.8357, p = 0.4412; Fig. 3j). Tph2Δ+/+, Tph2Δfl/− and Tph2Δfl/fl 
mice differed significantly in the total distance traveled (one-way ANOVA,  F(2,39) = 6.224, p = 0.0045; Fig. 3k). 
Indeed, Tph2Δfl/− traveled longer distances than Tph2Δ+l+ and Tph2Δfl/fl (p = 0.004). Furthermore, a tendency 
in favor of Tph2Δfl/− was seen in jumping activity  (F(2,39) = 2.944, p = 0.0644; Fig. 3l). In the LDT, Tph2Δfl/− and 
Tph2Δfl/fl mice did not differ from Tph2Δ+/+ mice in all behavioral measures including entries and time spent 
in the lit compartment as well as total distance traveled (Fig. 3b–d). However, vertical rearing activities varied 
between groups  (F(2,41) = 5.865, p = 0.0058). Here Tph2Δ+/+ and Tph2Δfl/− mice differed significantly (p = 0.0379; 
Fig. 3e). In the EPM, Tph2Δ+/+, Tph2Δfl/− and Tph2Δfl/fl mice showed similar results regarding the frequency of 
visits to the open arms  (F(2,24) = 0.7034, p = 0.5048; Fig. 3f), time spent on open arms  (F(2,24) = 0.5964, p = 0.5587; 
Fig. 3g) and total distance traveled  (F(2,24) = 0.7257, p = 0.4943; Fig. 3h).
Behavioral despair and anhedonia were tested in the FST and sucrose preference test. Tph2Δ+/+, Tph2Δfl/− and 
Tph2Δfl/fl mice did not show any significant variation in latency to floating  (F(2,24) = 0.2681, p = 0.7671; Fig. 3m) 
and duration of immobility (one-way ANOVA,  F(2,24) = 0.0737, p = 0.9291; Fig. 3n). Of note, Tph2Δ+/+ mice did 
not differ in behaviour to vehicle treated Tph2fl/fl mice (Fig. S2). Tph2Δfl/− and Tph2Δfl/fl mice consumed more 
fluid than Tph2Δ+/+ mice  (F(2,22) = 3.585, p = 0.0449; Fig. 3o) with Tph2Δ+/+ consuming significantly less fluid that 
Tph2Δfl/− (p = 0.0384) and a tendency in comparison with Tph2Δfl/fl mice (p = 0.0992). In the SPT, differences 
in preference for sucrose were detected  (F(2,22) = 5.972, p = 0.0085; Fig. 3p) such that Tph2Δfl/fl (p = 0.0301) and 
Tph2Δfl/− (p = 0.0076) preferred sucrose more than Tph2Δ+/+.
Finally, we assessed whether reduced adult brain 5-HT synthesis affects body weight, food and water con-
sumption in mice. There was no difference in body weight  (F(2,61) = 0.3954, p = 0.6751; Fig. 3c). However, experi-
mental groups showed a statistical tendency towards quantity of water consumed  (F(2,61) = 3.059, p = 0.0542; 
Fig. S3b), with Tph2Δfl/− drinking more water. This is in line with Tph2Δfl/− consuming a significant higher quantity 
of food  (F(2,61) = 18.98, p < 0.0001; Fig. S3a) than Tph2Δ+/+ (p < 0.0001).
Anxiety- and depression-like behavior in MS-exposed mice. Several studies suggested that the 
functionality of 5-HT in adulthood may be primed by early-life adversity to render an individual susceptible to 
emotion related  disorders38–40. Therefore,  TgTph2creERT2/Tph2fl/fl mice, were subjected to MS stress from P2-P16, 
injected with TAM in adulthood and tested for anxiety- and depression-like behavior (Fig. 4a).
In the OF test, no MS × treatment interaction in the number of visits to the center  (F(1,32) = 2.275; p = 0.1413; 
Fig. 4h) was detected. Considering the total time spent in the center, a significant MS × treatment interaction 
effect  (F(1,32) = 6.562; p = 0.015; Fig. 4i) was observed. In the Non-MS group, Tph2Δfl/fl mice showed a tendency 
towards  less time in the center (p = 0.077) compared with Tph2 CON. Inter-group comparison revealed that Non-
MS Tph2Δfl/fl mice were more anxious than MS-exposed Tph2Δfl/fl mice (p = 0.035). Furthermore, MS exposure 
potentially increased total distance travelled in the aversive center  (F(1,32) = 6.562; p = 0.09; Fig. 4j).
In the LDT, mice were assessed based on their activities in the open compartment of the box. Two-way 
ANOVA revealed no significant MS × treatment interaction in measures of anxiety  (F(1,32) = 0.9622; p = 0.334, 
Fig. 4b,c) and overall distance  (F(1,32) = 0.6689; p = 0.4195) travelled. However, Non-MS mice covered longer 
distance than MS exposed mice  (F(1,32) = 12.49; p = 0.0013) and Tph2Δfl/fl mice were more active compared to 
Tph2 CON mice  (F(1,32) = 4.672; Fig. 4d).
In the EPM, no significant MS × treatment interaction effect of was observed in visits to open arms 
 (F(1,31) = 0.1966; p = 0.6605; Fig. 4e), total time spent on open arms  (F(1,31) = 0.002; p = 0.9644; Fig. 4f) and the over-
all distance covered  (F(1,31) = 0.2576; p = 0.6153). However, MS exposed mice  (F(1,31) = 12.41; p = 0.0014) covered 
less distance than Non-MS mice, while Tph2Δfl/fl mice  (F(1,31) = 5.392; p = 0.027; Fig. 4g) covered longer distance 
than Tph2 CON mice, independent of MS exposure.
Evaluation of depression-like behavior in the PST in both MS- and Non MS-exposed mice revealed no 
behavioral deficits  (F(1,31) = 0.3670; p = 0.549; Fig. 4k,l).
Furthermore the SPT showed no significant effects on sucrose preference  (F(1,31) = 0.3531; p = 0.5566; Fig. 4m). 
With respect to total fluid consumed, a significant main effect of treatment occurred  (F(1,31) = 20.9; p < 0.0001; 
Fig. 4n). Tph2Δfl/fl mice consumed more fluid than Tph2 CON mice independent of aversive early-life stress 
experience. These outcomes indicate that reduction in adult brain 5-HT concentrations may not predispose 
to lack of pleasure that characterizes anhedonia but rather increases energy metabolism similar to constitutive 
Tph2  KOmice20,71.
Gene expression. The effect of MS-induced anxiety-related behavior on expression of genes, that are viewed 
as indicators of 5-HT system functionality  in the raphe region, hippocampus and amygdala was also exam-
ined. Tph2 expression indicated no significant MS × treatment interaction in the raphe region  (F(1,31) = 0.1104; 
p = 0.7419). However, a significant main effect of treatment  (F(1,31) = 30.05; p < 0.0001) was apparent (Fig. 5a). 
Thus, expression of Tph2 was significantly reduced both in Non-MS and MS-exposed Tph2icKO mice which 
confirms the efficiency of conditional Tph2 inactivation.
The relative expression of Htr1a in the raphe showed a significant main effect of treatment  (F(1,31) = 4.345; 
p = 0.0456; Fig. 5b) and a strong trend in the effect of MS  (F(1,31) = 3.597; p = 0.0672; Fig. 5d). No change in hip-
pocampus and amygdala was detected (Fig. S4c).
Relative expression of Htr2a in the raphe region indicated no significant MS × treatment interactions 
 (F(1,31) = 0.3917; p = 0.536) mice but a significant main effect of MS  (F(1,31) = 7.599; p = 0.0097) and a trend towards 
treatment  (F(1,31) = 3.328; p = 0.0778; Fig. 5c). No alterations in hippocampus and amygdala were detected (Fig. 
S4b).
Assessment of Maoa expression responsible for the degradation of 5-HT in the raphe revealed a general 
effect of TAM treatment with significantly lower expression in Tph2 icKO than Tph2 CON mice  (F(1, 31) = 13.39; 
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Figure 4.  Anxiety-like, depression-like and exploratory behavior in MS-exposed Tph2 icKO mice with 
homozygous genetic predisposition (Tph2Δfl/fl). (a) Timelines for behavior testing; (b)–(d) LDB: light box visits, 
time in light box, total distance; (e)–(g) EPM: open arms visits, time in open arms and total distance; (h)–(j) 
OFT: center visits, time in center, total distance; (k),(l) FST: latency to float and floating duration; (m),(n) SPT: 
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p = 0.0009; Fig. 5d). By contrast, a main effect of MS occurred in target brain areas, such as hippocampus 
 (F(1, 31) = 4.399; p = 0.0442; Fig. S4c, upper panel) and amygdala  (F(1, 30) = 3.068; p = 0.09; Fig. S4c, lower panel). 
Avpr1a was reported to influence anxiety in humans and  rodents34. In this study a significant MS × treatment 
interaction  (F(1, 31) = 5.44; p = 0.0263; Fig. 5e) was observed in Avpr1a expression in raphe. Post-hoc analysis 
revealed Avpr1a expression in MS exposed Tph2 CON mice was higher than MS-exposed Tph2 icKO (p = 0.017). 
No differences were detected in the Non-MS cohort in both hippocampus and amygdala (Fig. S4d).
Discussion
The first part of this study capitalized on the TAM induced Cre-mediated inactivation of Tph2 to significantly 
reduce 5-HT synthesis in adult mouse brain. A transgenic Tph2-CreERT2 mouse line and the induction protocol 
described by (Weber et al. 2011) was used to induce a Tph2 knockout in adulthood. Although few 5-HT posi-
tive cells in the raphe region remained, which may point to ineffective nuclear translocation of Tph2-CreERT2 
probably due to reduced expression of Tph2 in certain 5-HT immunoreactive neurons, we achieved similar 
recombination efficiencies as reported for other induced Tph2 KO mice using CMV-CreERT2 transgenics as 
Cre driver  line41 or using AAV-Cre viral injection into the rostral raphe  nuclei42. Furthermore, measurement 
of 5-HT concentrations four weeks after TAM induction in the raphe, hippocampus and amygdala revealed 
efficiently reduced 5-HT concentrations in Tph2 icKO comparable to constitutive Tph2−/− null mutant  mice19.
Efficient reduction of brain 5-HT and 5-HIAA within 4 weeks of TAM treatment has previously been 
 reported43, which indicates that the TAM-mediated induction approach requires a relatively long time period 
before a significant deficiency in brain 5-HT concentration is established. However, the HPLC results showing low 
concentrations of 5-HT in Tph2Δ+/+ combined with highly increased 5HIAA levels at week 2 differed to previous 
results of non-injected Tph2+/+ mice in previous  studies19. The increased 5-HT turnover in wildtype controls 
due to the stressful TAM injection protocol may represent a short time adaptive mechanism of the 5-HT system 
probably similar to restraint stress  models44. Although, 5-HT concentrations in Tph2Δfl/− and Tph2Δfl/fl mice 
did not differ in comparison with  Tph2Δ+/+, the low 5-HIAA levels in both Tph2Δfl/− and Tph2Δfl/fl groups reflect 
reduced 5-HT turnover similar to  Tph2−/− null mutant mice in the  DRN19. Nevertheless, it seems that it takes at 
least four weeks in Tph2Δ+l+ mice to recover from the injection stress indicated by increasing 5-HT concentrations 
in the DRN similar to that of Tph2+l+ wildtype mice without any  injection19. Interestingly, in the hippocampus 
and amygdala this effect on  Tph2Δ+/+ is detected as well but it seems that it takes longer after TAM injections 
that 5-HT levels become degraded as compared to the raphe nuclei, which might be due to differentially edited 
or spliced Tph2 mRNA isoforms with enhanced stability itself and or its coding  proteins45 within serotonergic 
projections targeting these regions. Still, remaining 5-HT in induced Tph2Δfl/− and Tph2Δfl/fl mice may arise from 
blood platelet 5-HT due to inefficient perfusion of the brain and/or from blood-borne 5-HTP derived from Tph1 
enzymatic activity, which may cross the blood brain barrier and be converted into 5-HT by  AADC16,19.
In line with the above explanation is an early increased concentration of NE in the brain coupled with 
expected reduction in 5-HT concentrations, which was probably caused by the injection  procedure44. This shows 
that acute stress coupled with reduced 5-HT metabolism has an immediate influence on the NE and dopamine 
Figure 5.  Expression of genes representing markers of 5-HT system function in the raphe region of 
MS-exposed Tph2 icKO mice with homozygous genetic predisposition. After behavioral testing maternally 
separated (MS) and normally reared non-MS  Tph2fl/fl::Tph2CreERT2 (fl/fl) mice, which were either injected at 
10–12 weeks of age with TAM (Δfl/fl) or vehicle (CON) were analysed for differential expression of (a) Tph2, (b) 
Htr1a, (c) Htr2a, (d) Maoa, (e) Avpr1. Data are shown as mean ± SEM. #0.05 < p < 0.1, **p < 0.01 and ***p < 0.001.
10
Vol:.(1234567890)
Scientific Reports |         (2021) 11:5368  | https://doi.org/10.1038/s41598-021-83592-4
www.nature.com/scientificreports/
 systems42. An effect, which normalized in the 4th week after TAM injections. Thus, the observed alterations in 
brain DA and NE concentrations add on the results from other  studies42,43.
Interestingly, unlike Tph2−/− mice, which exhibit reduced anxiety-like  behavior21,22,46, Tph2Δfl/− and Tph2Δfl/fl 
mice showed no differences in anxiety- and depression-like behavior. However, locomotor hyperactivity or 
panic-like responses in aversive inescapable novel environment in Tph2−/−  mice32 and locomotor hyperactivity 
as described for Tph2icko  mice42 were specifically observed in Tph2Δfl/−, which resemble genetic heterozygous 
knockout mice with a 20–30% reduction in raphe 5-HT  levels19. This is in line with reports of involvement of 
DR and MnR 5-HT in responses to future  threat47,48. In contrast, Tph2Δfl/fl did not differ in any behavioral assess-
ment compared to Tph2Δ+/+mice. Indeed, it points towards a two-hit  effect49. Based upon a primed heterozygous 
genetic background during development, an induced or acquired 5-HT deficiency may provoke more pronounced 
panic-like flight responses in inescapable aversive conditions, while a development without changes in the 5-HT 
system like in Tph2Δfl/fl is able to compensate further environmental or genetic impacts in adulthood despite the 
near complete ablation of 5-HT synthesis.
Interaction of early life MS stress and aberrant adult brain 5-HT on behavior. In order to further 
investigate this effect during early development, we used early life MS, which has been commonly used to study 
G × E interaction on anxiety and depression in  mice50,51 and has been shown to impact anxiety-like behaviors 
in rodents via the 5-HT  system52,53. Exposure of wildtype mice, on a mixed c57BL6/J–129S6/Sv background, to 
MS significantly decreased distance travelled and time spent in the center of the OFT, while MS had no effect in 
Tph2 KI  mice54. Here, we could show that MS produced a similar effect in vehicle injected Tph2fl/fl control mice 
and this effect was rescued by inducing a Tph2 deficiency. This shows that MS exposure and reduced brain 5-HT 
differentially influence anxiety-like behavior and may compensate each other.
Thus, this study complements numerous studies, which focused specifically on manipulation of Tph2 expres-
sion in adult mouse brain and its effect on emotion-related  behavior42. Aberrant 5-HT neurotransmission in the 
adult brain either via pharmacological  interventions55,56 or induced gene  inactivation42,43 was unable to destabilize 
behavioral adaptive mechanisms that are established during early brain maturation.
Notably, neither MS nor induced adult 5-HT deficiency altered preferences for sucrose solution indicating 
no differences in hedonic-like behaviors. Furthermore, no alterations in depression-like behavior in the PST 
were observed in this study. One explanation may be that maternal care on reunion with pups increased and this 
may have dissolved the MS effect on depression-like behaviors. Thus, it may well be that the MS protocol used 
was not robust enough to impact depression-like behavior in the  mice57 and requires further studies including 
investigation of maternal behaviour. MS exposure neither affected hedonic behavior in  rats58, nor did it impact 
anxiety- and depression-related behavior in C57BL/6  mice59. Even in TPH2 KI mice, which have reduced brain 
5-HT concentrations throughout life, MS exposure did not alter anxiety- and depressive-like  behaviors60. By 
contrast, some studies have associated MS exposure with abnormal behavior and stress induced alteration in 
neurotransmitter  concentration61,62. Noteworthy, most rodent studies, which found an association between MS 
with behavioral alterations, were largely done in  rats62–64. Indeed, some C57BL/6 mouse strains appear to be 
resilient to neonatal MS  stress57,59,65–70, which may explain the weak MS effects observed in this study.
However, Tph2 icKO mice consumed more fluid than Tph2 CON mice, which points towards an acute 
metabolic effect of 5-HT deficiency in Tph2 KO  mice71. The observed increase in food, water and percentage 
sucrose consumption by Tph2Δfl/− and Tph2Δfl/fl mice has also been reported in Tph2−l−  mice20,71, which reflects 
an increased energy need, rather than altered anhedonia as a symptom of depressive-like behavior. This supports 
the assertion that strong reductions in 5-HT metabolism in adulthood are implicated in the pathophysiology 
of eating disorders through various hormonal and receptor  systems72,73, independent of 5-HT functions during 
development.
Gene expression in raphe, hippocampus and amygdala. Early-life stress does not alter the expres-
sion of Tph2 in  mice60 and  rats52. In contrast, an association between MS exposure and raphe region-specific 
reduction in Tph2 expression of C56BL/6 J mice has been  reported74. Here, the relative expression of Tph2 in 
Tph2 icKO was significantly lower than Tph2 CON mice in raphe, while MS exposure alone did not alter Tph2 
expression.
We detected no differences in expression of Htr1a, Htr2a and Avpr1a in target regions of MS-naive mice. This 
confirms our earlier work, which also reporting no change in expression of Htr1a and Htr2a genes in non-stressed 
Tph2 conditional KO  mice75. A slightly altered expression of Maoa in amygdala and hippocampus may point to 
specific compensatory mechanisms due to  MS53. Furthermore, MS exposed mice showed altered expression of 
Htr1a and Htr2a in the raphe independent of Tph2 icKO, which is in line with previous MS  studies76,77. Altera-
tions in 5-HT receptors in target regions of 5-HT neurons have previously been associated with altered anxiety 
and exploratory  behavior78. Here, this may explain the dampening effect of MS on total locomotor activity in 
OF and EPM.
However, a Tph2 icKO reduced expression of Maoa in the raphe region, pointing towards a direct effect of 
strong 5-HT depletion on MaoA dependent 5-HT turnover processes. Thus, effects mediated by adverse life 
experience and associated with altered Maoa  expression34 may be prohibited in Tph2 icKO mice through a 
dysfunctional 5-HT system in adulthood. Interestingly, Avpr1a expression was only affected in the raphe after 
the mice were maternally separated. We did not find altered Avpr1a expression in the hippocampus, which 
was correlated after late adverse life experiences with reduced anxiety-like  behavior34. Nevertheless, Avpr1a 
is present in the dorsal raphe, the mesencephalic central gray and the caudal linear  raphe79. Additionally, an 
Avpr1a knockout as well as pharmacological blockade of Avpr1a function in rodents reduced aggression and 
resulted in anxiolytic and anti-depressive-like  effects80,81. Thus, the potential anxiolytic effect observed in MS 
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Tph2 icKO mice may be directly attributable to altered Avpr1a expression. This highlights the interaction of 
arginine vasopressin-dependent signaling with the 5-HT system in the brainstem following MS as a potential 
therapeutic target for treating emotional dysregulation.
In conclusion. Our findings establish a "double-hit" experimental model to study the behavioral and neurobio-
logical consequences of 5-HT deficiency in adulthood in interaction with early-life stress experience potentially 
affecting emotion regulation and the pathogenesis of depressive disorders.
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